Hird, A. E., D. E. Magee, D. C. Cheung, R. Matta, G. S. Kulkarni, and R. K. Nam. “Abiraterone Vs. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: A Microsimulation Model”. Canadian Urological Association Journal, vol. 14, no. 9, Mar. 2020, pp. E418-27, doi:10.5489/cuaj.6234.